ALT5 Sigma Reports a Record Month at Over $240 Million in Transaction Volume
ALT5 Sigma (NASDAQ:ALTS) reported a record transaction volume of over $240 million for September 2024, representing a 151% year-over-year increase from September 2023. The company's year-to-date transaction volume reached approximately $1.5 billion, with Q3 exceeding $600 million, marking a record quarter. ALT5 Sigma, a fintech company providing blockchain-powered technologies for digital asset services, attributes this growth to realigned sales and marketing efforts, global tradeshow presence, new customer onboardings, and increased flows from existing customers.
The company offers two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform for digital assets. In 2023, ALT5 Sigma processed over $1.2 billion in cryptocurrency transactions. The company is also involved in biotech activities, focusing on developing innovative solutions to address the opioid crisis.
ALT5 Sigma (NASDAQ:ALTS) ha riportato un volume di transazioni record di oltre 240 milioni di dollari per settembre 2024, corrispondente a un aumento del 151% rispetto all'anno precedente rispetto a settembre 2023. Il volume delle transazioni dall'inizio dell'anno ha raggiunto circa 1,5 miliardi di dollari, con il terzo trimestre che ha superato i 600 milioni, segnando un trimestre record. ALT5 Sigma, una società fintech che fornisce tecnologie basate su blockchain per i servizi di asset digitali, attribuisce questa crescita alla riallineamento degli sforzi di vendita e marketing, alla presenza in fiere commerciali globali, all'acquisizione di nuovi clienti e all'aumento dei flussi provenienti da clienti esistenti.
La società offre due piattaforme principali: ALT5 Pay, un gateway di pagamento in criptovalute, e ALT5 Prime, una piattaforma di trading elettronico over-the-counter per asset digitali. Nel 2023, ALT5 Sigma ha elaborato oltre 1,2 miliardi di dollari in transazioni di criptovaluta. L'azienda è anche coinvolta in attività biotecnologiche, focalizzandosi sullo sviluppo di soluzioni innovative per affrontare la crisi degli oppioidi.
ALT5 Sigma (NASDAQ:ALTS) reportó un volumen de transacciones récord de más de 240 millones de dólares para septiembre de 2024, lo que representa un aumento del 151% interanual desde septiembre de 2023. El volumen de transacciones de la compañía hasta la fecha alcanzó aproximadamente 1,5 mil millones de dólares, con el tercer trimestre superando los 600 millones, marcando un trimestre récord. ALT5 Sigma, una empresa fintech que proporciona tecnologías impulsadas por blockchain para servicios de activos digitales, atribuye este crecimiento a un reajuste en los esfuerzos de ventas y marketing, la presencia en ferias comerciales globales, la incorporación de nuevos clientes y el aumento de flujos de clientes existentes.
La compañía ofrece dos plataformas principales: ALT5 Pay, una pasarela de pago de criptomonedas, y ALT5 Prime, una plataforma de trading electrónico over-the-counter para activos digitales. En 2023, ALT5 Sigma procesó más de 1,2 mil millones de dólares en transacciones de criptomonedas. La empresa también está involucrada en actividades biotecnológicas, centrándose en desarrollar soluciones innovadoras para abordar la crisis de los opioides.
ALT5 시그마(NASDAQ:ALTS)는 2024년 9월에 2억 4천만 달러 이상의 거래량 기록을 보고했으며, 이는 2023년 9월 대비 151%의 연간 증가를 나타냅니다. 회사의 올해 누적 거래량은 약 15억 달러에 도달하였으며, 3분기에는 6억 달러를 초과하여 기록적인 분기를 기록했습니다. 블록체인 기반 디지털 자산 서비스 기술을 제공하는 핀테크 회사인 ALT5 시그마는 이 성장을 판매 및 마케팅 노력을 재조정하고, 국제 전시회에 참여하고, 신규 고객을 onboard하며, 기존 고객으로부터의 증가된 흐름 덕분으로 보고 있습니다.
회사는 두 개의 주요 플랫폼을 제공합니다: ALT5 Pay, 암호화폐 결제 게이트웨이와 ALT5 Prime, 디지털 자산을 위한 전자 장외 거래 플랫폼. 2023년 동안 ALT5 시그마는 12억 달러 이상의 암호화폐 거래를 처리했습니다. 회사는 또한 생명공학 활동에 참여하고 있으며, 오피오이드 위기를 해결하기 위한 혁신적 솔루션 개발에 집중하고 있습니다.
ALT5 Sigma (NASDAQ:ALTS) a annoncé un volume de transactions record de plus de 240 millions de dollars pour septembre 2024, représentant une augmentation de 151% par rapport à l'année précédente par rapport à septembre 2023. Le volume des transactions de l'entreprise depuis le début de l'année a atteint environ 1,5 milliard de dollars, le troisième trimestre dépassant les 600 millions, marquant un trimestre record. ALT5 Sigma, une entreprise fintech fournissant des technologies basées sur la blockchain pour des services d'actifs numériques, attribue cette croissance à un réalignement des efforts de vente et de marketing, à une présence dans des salons internationaux, à l'intégration de nouveaux clients et à une augmentation des flux provenant de clients existants.
L'entreprise propose deux plateformes principales : ALT5 Pay, une passerelle de paiement en cryptomonnaies, et ALT5 Prime, une plateforme de trading électronique de gré à gré pour des actifs numériques. En 2023, ALT5 Sigma a traité plus de 1,2 milliard de dollars en transactions de cryptomonnaies. L'entreprise est également impliquée dans des activités biotechnologiques, se concentrant sur le développement de solutions innovantes pour faire face à la crise des opioïdes.
ALT5 Sigma (NASDAQ:ALTS) meldete ein Rekordtransaktionsvolumen von über 240 Millionen Dollar für September 2024, was einem 151%igen Anstieg im Jahresvergleich gegenüber September 2023 entspricht. Das Transaktionsvolumen des Unternehmens im laufenden Jahr erreichte ungefähr 1,5 Milliarden Dollar, wobei das dritte Quartal über 600 Millionen überschritt und damit ein Rekordquartal markierte. ALT5 Sigma, ein Fintech-Unternehmen, das blockchainbasierte Technologien für digitale Vermögensdienste anbietet, führt dieses Wachstum auf eine Neuausrichtung der Vertriebs- und Marketingmaßnahmen, die Präsenz auf internationalen Messen, die Akquise neuer Kunden und erhöhte Flüsse von bestehenden Kunden zurück.
Das Unternehmen bietet zwei Hauptplattformen an: ALT5 Pay, ein Kryptowährungszahlungen Gateway, und ALT5 Prime, eine elektronische Over-the-Counter-Handelsplattform für digitale Vermögenswerte. Im Jahr 2023 verarbeitete ALT5 Sigma über 1,2 Milliarden Dollar an Kryptowährungstransaktionen. Das Unternehmen ist auch in biotechnologischen Aktivitäten tätig und konzentriert sich darauf, innovative Lösungen zur Bewältigung der Opioidkrise zu entwickeln.
- Record transaction volume of $240 million in September 2024, a 151% year-over-year increase
- Year-to-date transaction volume of approximately $1.5 billion
- Record Q3 with over $600 million in transaction volume
- Processed over $1.2 billion in cryptocurrency transactions in 2023
- Expanded customer base and increased flows from existing customers
- Added staff in customer onboarding/compliance group due to robust pipeline
- None.
Insights
ALT5 Sigma's record-breaking transaction volume of
The company's strategic realignment of sales and marketing resources has yielded immediate benefits, as evidenced by increased customer onboarding and higher transaction flows. This growth has necessitated additional staffing in customer onboarding and compliance, suggesting scalable operations and potential for further expansion.
For investors, this robust growth in transaction volume could translate to increased revenue and market share in the competitive fintech space. However, it's important to monitor whether this volume growth will directly correlate with profitability and sustainable long-term value creation. The company's dual focus on fintech and healthcare, particularly its efforts in addressing the opioid crisis, presents a unique value proposition but also requires careful allocation of resources and strategic execution across diverse sectors.
ALT5 Sigma's blockchain-powered platforms, ALT5 Pay and ALT5 Prime, are demonstrating significant traction in the digital asset space. The
The company's integration capabilities with popular e-commerce platforms like WooCommerce, along with API offerings, position it well in the evolving crypto payment gateway market. The option for merchants to automatically convert to fiat or receive payments in digital assets provides flexibility that could drive further adoption.
The ALT5 Prime platform's multi-channel accessibility, including browser-based, mobile app and FIX API, shows a commitment to user convenience and could appeal to a broad range of traders. The integration with Broadridge Financial Solutions' NYFIX gateway also suggests potential for institutional adoption.
Investors should monitor the company's ability to maintain security, scalability and regulatory compliance as transaction volumes grow, as these factors are critical for long-term success in the fintech sector.
LAS VEGAS, NV / ACCESSWIRE / October 9, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, released its transaction volume for September 2024.
According to the company, ALT5's transaction volume exceeded US
Vay Tham, CRO of ALT5 Sigma Corporation, exclaimed, "The realignment of our sales and marketing resources has resulted in immediate benefits.
About ALT5 Sigma
The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.
Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US
ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.
Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Media Contact Investor Relations
IR@alt5sigma.com
1-800-400-2247
Contact Information
Investor Relations
Investor Relations
ir@alt5sigma.com
1-800-400-2247
SOURCE: ALT 5 Sigma
View the original press release on accesswire.com
FAQ
What was ALT5 Sigma's (ALTS) transaction volume for September 2024?
How much did ALT5 Sigma's (ALTS) transaction volume increase compared to September 2023?
What is ALT5 Sigma's (ALTS) year-to-date transaction volume for 2024?
How much did ALT5 Sigma (ALTS) process in cryptocurrency transactions in 2023?
